Latest therapeutics News

Promising Role Of Antidiabetic Drug In Cancer Control
New Investment: Fight Against MND Continues
Key To Improving Cancer Treatments Discovered
Govt Strengthens COVID-19 Preparedness
Research to limit COVID-19 risk in people with Down syndrome
Sepsis: why this deadly condition is so hard to diagnose
Astrocytes Induce Sex-specific Effects On Memory
Visit to the United States to showcase a Future Made in Australia
UQ secures global partnership to create homegrown lifesaving vaccines
Best Translational Research Awarded At AusMedtech 2024
Research Excellence: A new paradigm for how APOE genotype affects brain lipid homeostasis and dementia risk
‘Cloaked’ proteins deliver cancer-killing therapeutics into cells
Dimerix announces Middle East license agreement for DMX-200
New health research hub to improve patient care and build health workforce in Victoria’s northern corridor
Up to $5 million In Funding Available for Dementia and Cognitive Decline Innovations Through CUREator+
New centre to bring more international eye clinical trials to Victoria
Ground-breaking progress made in Member State negotiations on amendments to the International Health Regulations (IHR)
PYC Therapeutics plans to progress candidate to human clinical trials
Cell & Gene Catalyst champions industry at BioKorea 2024
PASO Fellowship Cements Hudson’s Lung Cancer Leadership
Therapeutic Products Act to be repealed
Making the most of health technology could save billions
CUREator deploys $7.21 Million to propel local life sciences potential
Technology shines a light on better bladder cancer detection
Funding Australia’s Future Economy: CUREator Deploys $7.21 Million to Propel local Life Sciences Potential
What Does Future Of Heart Research Hold?
New Drug Candidate Reverses Obesity In Mice
Consumer Health Literacy and Health Professional Education Grant Opportunity Forum presentation
Professor Mimi Tang Receives Distinguished Leadership Award
BMS and Australian venture capital firm back immunotherapy company Pathios Therapeutics
Chemical pollutants can change your skin bacteria and increase your eczema risk − new research explores how
Swinburne and UIIN showcase university-industry collaboration
Seaport Therapeutics receives $100 million in funding to maximise Monash invention
AusBiotech Welcomes Medical Science Co-Investment Plan
Breakthrough Discovery In Fight Against Liver Disease
Seaport Therapeutics receives $100 million in funding to maximise Monash invention
Starpharma partners with UK investment firm to create Petalion Therapeutics
Breakthrough Test Can Evaluate Enzyme Involved in Process Associated with Cancer Cell Death
Opthea Appoints Sujal Shah To Its Board Of Directors
Percheron Therapeutics provides update on ATL1102 Duchenne muscular dystrophy trial
Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization
New Hope In Immunotherapy Against Cancer
Stakeholder Forum – Health Professional Education and Consumer Health Literacy
Monash University pharmaceutical scientists honoured in NHMRC Research Excellence Awards
Gut microbiota and antibiotics: Missing puzzle piece discovered
Consortium identifies 5 grand challenges in biomedical engineering
Study Shines New Light On Immune Response
Dash Heath-Paynter confirmed as Health Equity Matters CEO